Choi, Joon Young
Park, Yong Bum
An, Tai Joon
Yoo, Kwang Ha
Rhee, Chin Kook
Funding for this research was provided by:
the Aju Pharm Co., Ltd., Seoul, Republic of Korea
Article History
Received: 1 December 2022
Accepted: 19 September 2023
First Online: 7 October 2023
Declarations
:
: This study was approved by the Institutional Review Board of Konkuk University Hospital, Republic of Korea with registration number KUMC 2021–02-001–003. Informed consent from patients was waived by the Institutional Review Board of Konkuk University Hospital. We confirm that all methods were performed in accordance with the Declaration of Helsinki and the relevant guidelines and regulations.
: Not applicable.
: CK Rhee received consulting/lecture fees from MSD, AstraZeneca, GSK, Novartis, Takeda, Mundipharma, Boehringer-Ingelheim, Teva, Sanofi, and Bayer.JY Choi, TJ An, YB Park, KH Yoo had no competing interests.